Premium IOLs in Imperfect Eyes  - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Premium IOLs in Imperfect Eyes 

Kavitha R. Sivaraman, MD, ABO and Dagny Zhu, MD, ABO discuss premium options for patients with corneal pathology and post-refractive corneas.

  • April 11, 2026

  • 6 min

Share

Objective:

Specify the target audience for the guidelines.

Approach:
    Key Findings:
    • Add implications of findings for practice.
    Interpretation:

    Emphasize the importance of individualized assessments.

    Limitations:
    • Expand on potential biases or gaps in content.
    Conclusion:

    Reiterate the importance of ongoing education for surgeons.

Original Source(s)

Premium IOLs in Imperfect Eyes 

  • April 11, 2026

Related Content

Pinhole Optics Meet Cataract Surgery

Small-aperture IOL shows promise for cataract patients with pre-existing corneal comorbidities

  • July 28, 2026

  • 3 min
Clobetasol Suspension Eases Cataract Inflammation

Phase 3 trials show clobetasol propionate ophthalmic suspension rapidly reduced inflammation and pain after cataract surgery

  • July 6, 2026

  • 3 min
An Open Letter from a Retina Specialist to Cataract Surgeons

Why thorough retinal screening before cataract surgery can safeguard outcomes, shape surgical planning, and reveal risks hiding beyond the lens